BioNTech SE (BNTX) Reports Q4 EPS of EUR12.18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- AMD stock jumps as chip rally builds ahead of summit
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
March 30, 2022 6:00 AM EDTFourth quarter and full year revenues of 5.5 billion1 and 19.0 billion1, respectivelyFull year net income of 10.3 billion and fully diluted earnings per share of 39.63 ($46.872)Expect to authorize a share repurchase program of up to $1.5 billion over the next two years and will propose a special cash dividend of 2.00 per share, pending approval at the Annual General MeetingApproximately 2.6 billion doses of COMIRNATY®/BNT162b2 delivered to more than 165 countries and regions worldwide in 2021, including more than 1 billion doses to low- and middle-income... More
